Sessions Were Renumbered as of May 19.
Legend:
CC-W = McCormick Place Convention Center, West Building,
CC-N = McCormick Place Convention Center, North Building
H = Hilton Chicago,
UC = Conference Chicago at University Center
* = applied session ! = JSM meeting theme
137 * !
Mon, 8/1/2016,
8:30 AM -
10:20 AM
CC-W186a
Topics in Oncology Clinical Trial Design and Drug Development — Contributed Papers
Biopharmaceutical Section
Chair(s): Elande Baro, FDA
8:35 AM
Graphical Testing Procedure in a Hypothetical Seamless Phase II/III Oncology Study
—
Jiacheng Yuan, Bayer HealthCare Pharmaceuticals ; Jonathan Siegel, Bayer HealthCare Pharmaceuticals ; Daniel Haverstock, Bayer HealthCare Pharmaceuticals
8:50 AM
The Rapid Enrollment Design for Phase I Clinical Trials
—
Yunfei Wang, Children's National
9:05 AM
Paired Survival Endpoints in Crossover Trials
—
Rengyi Xu, University of Pennsylvania ; Devan V. Mehrotra, Merck ; Pamela A. Shaw, University of Pennsylvania
9:20 AM
Multiplicity Adjustment Considerations in Designing a Confirmatory Oncology Clinical Trial with Multiple Endpoints
—
Di Li
9:35 AM
A New Design for Drug Combination in Phase I Dose-Finding Clinical Trials
—
Jim Xiang, Janssen ; Grace Liu, Johnson & Johnson ; James Pan, Janssen
9:50 AM
Benefit-Risk Analysis for Dose-Escalation Trial
—
Hiya Banerjee
10:05 AM
Floor Discussion
